Patents
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
12/2012
12/11/2012US8329619 Substituted quinolinones having herbicidal action
12/06/2012WO2012167237A2 Compounds having antiparasitic or anti-infectious activity
12/06/2012WO2012164085A1 Glycine b antagonists
12/06/2012US20120309758 Modulators of atp-binding cassette transporters
12/06/2012US20120309751 Tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof
12/06/2012US20120308606 Bicyclic derivatives as modulators of voltage gated ion channels
12/05/2012EP2530075A2 Modulators of ATP-binding cassette transporters
12/05/2012EP2528893A2 Small molecules for the modulation of mcl-1 and methods of modulatiing cell death, cell division, cell differentiation and methods of treating disorders
12/05/2012CN101045725B Malate and multicrystal object of some quinolone compound
12/04/2012US8324384 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
12/04/2012US8324245 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same
12/04/2012US8324244 Process and intermediates for preparing integrase inhibitors
12/04/2012US8324243 Derivatives of the aminated hydroxyquinoline class for treating cancers
12/04/2012CA2674543C Quinolone carboxylic acids, derivatives thereof, and methods of making and using same
12/04/2012CA2618362C Hindered cyclic polyamines and their salts for acid gas scrubbing process
11/2012
11/29/2012WO2011140682A8 (2e)-3-phenyl-n-[2,2,2-trifluoro-1-[[(8-quinolineamino)thiomethyl]amino]ethyl]-2-acrylamide and pharmaceutical uses thereof
11/29/2012US20120302582 Novel bifunctional metnase/intnase inhibitors and related compositions and methods of treatment of cancer
11/29/2012US20120302576 Ampk modulators
11/29/2012US20120302531 beta-2-Adrenoreceptor Agonists
11/29/2012US20120301552 CaSR Antagonist
11/28/2012EP2526092A1 Amino heteroaryl compounds as beta-secretase modulators and methods of use
11/28/2012CN202555255U Variable-diameter tower reactor capable of carrying out continuous reaction
11/28/2012CN102800878A Integrated direct fuel cell energy storing and supplying system based on liquid hydrogen storage material
11/28/2012CN102800877A Parallel direct fuel cell energy storage and supply system based on liquid hydrogen storage material
11/28/2012CN102796043A Method for preparing quinclorac hydrochloride
11/28/2012CN102796042A Method for catalytically oxidizing quinclorac
11/28/2012CN102796041A Quinoline thiourea compound, and synthesis method and application thereof
11/28/2012CN101925578B 6-substituted-thio-2-amino-quinoline derivatives useful as inhibitors of ss-secretase (BACE)
11/27/2012US8318956 Spiroheterocyclic tetronic acid derivatives
11/27/2012US8318770 Tetrahydroquinoline indole derivatives and uses thereof
11/27/2012US8318769 Substituted sulfonamide compounds
11/27/2012US8318748 Cathepsin cysteine protease inhibitors
11/27/2012CA2531766C Entry inhibitors of the hiv virus
11/27/2012CA2487805C Peptide deformylase inhibitors
11/27/2012CA2449830C New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
11/22/2012WO2012158885A1 Deuterated derivatives of ivacaftor
11/22/2012WO2012158568A1 Compounds for stem cell differentiation
11/22/2012US20120295988 Pharmaceutical Compositions of Dispersions of Amorphous Drugs Mixed with Polymers
11/22/2012US20120294808 Fluorescent Analogs of Neurotransmitters, Compositions Containing the Same and Methods of Using the Same
11/22/2012CA2834574A1 Deuterated derivatives of ivacaftor
11/21/2012EP2523937A1 Multiphoton activable quinoline derivatives, their preparation and their uses
11/21/2012CN1930127B Process for the synthesis of cxcr4 antagonist
11/21/2012CN1474803B Novel amide derivatives and medicinal use thereof
11/21/2012CN102786512A N-aryl unsaturated fused ring tertiary amine compound, preparation method thereof and application thereof to tumor resistance
11/21/2012CN102786482A Akt蛋白激酶抑制剂 Akt protein kinase inhibitor
11/21/2012CN102786470A Preparation method of indanylidene compound
11/21/2012CN102786394A Substituent bis-aryl methylene naphthenic base derivative as well as preparation method and application thereof
11/21/2012CN102786375A 9-alkyl alkenyl-2,7-diaryl fluorene derivate and application of 9-alkyl alkenyl-2,7-diaryl fluorene derivate
11/21/2012CN101906053B 酰胺衍生物 Amide derivatives
11/21/2012CN101633639B High-purity fleroxacin compound
11/20/2012US8314257 Treatment of CRTH2-mediated diseases and conditions
11/20/2012US8314239 Modulators of cystic fibrosis transmembrane conductance regulator
11/20/2012US8314124 Crystalline salts of quinoline compounds and methods for preparing them
11/20/2012US8314087 Nitrogen-containing heterocyclyl ketones and methods of use
11/20/2012US8313732 Formoterol superfine formulation
11/15/2012WO2012154194A1 Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (nampt)
11/15/2012US20120289702 Nitrogen-containing heterocyclic compound and agricultural fungicide
11/15/2012CA2834745A1 Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (nampt)
11/14/2012EP2522670A1 Heterocyclic CRF receptor antagonists
11/14/2012EP2522659A2 Modulators of ATP-binding cassette transporters
11/14/2012EP2522658A1 Nitrogen-containing heterocyclic compound and agricultural/horticultural germicide
11/14/2012CN102776218A Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
11/14/2012CN102775347A Improved synthetic method for 4-bromomethyl-1,2-dihydroquinoline-2-one
11/14/2012CN102249996B 2-(quinoline-8-yl)carbonyl-cyclohexane-1,3-dione compounds
11/14/2012CN102060763B Preparation method of micro-powdery aripiprazole crystal form I or II
11/14/2012CN101068801B Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
11/10/2012CA2830838A1 Process for the preparation of an hiv integrase inhibitor
11/08/2012WO2012150204A1 Novel precursors of glutamate derivatives
11/08/2012US20120283256 New heterocycle compounds and uses thereof for the prevention or treatment of diseases involving formation of amyloid plaques and/or where a dysfunction of the app metabolism occurs
11/08/2012US20120283249 Novel compounds which have a protective activity with respect to the action of toxins and of viruses with an intracellular mode of action
11/08/2012US20120283216 Fungicidal 2-(bicyclic aryloxy)carboxamides
11/08/2012US20120282629 Enhancers of Protein Degradation
11/08/2012CA2834881A1 Novel precursors of glutamate derivatives
11/08/2012CA2834818A1 Novel solid forms of antibiotics
11/07/2012EP2520557A1 Novel precursors of glutamate derivatives
11/07/2012EP2519505A1 New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof
11/07/2012EP2519504A1 New secondary 8-hydroxyquinoline-7-carboxamide derivatives.
11/07/2012EP2519503A1 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents
11/07/2012CN102766098A Process and intermediates for preparing integrase inhibitors
11/07/2012CN102766094A Preparation method of novel anticoccidial drug decoquinate
11/07/2012CN102766093A Synthetic method of stable isotope labeling enrofloxacin
11/07/2012CN102766092A Method for synthesizing optically active tetrahydroquinoline derivative in presence of chiral spiro phosphoric acid serving as catalyst
11/07/2012CN102766091A Preparation method of 3-(3-quinolyl)-2-propyne-1-alcohol
11/07/2012CN102766090A Purification method of 3-(3-quinolyl)-2-propenyl-1-tert-butyl carbonate
11/07/2012CN102766089A 3-(3-quinolyl)-2-propenyl-1-halide and its preparation method
11/07/2012CN102766061A Dehydroabietic acid base diarylamine compound, synthesis method and application thereof
11/07/2012CN101868447B Method of making and administering quinoline derivatives as anti-cancer agents
11/07/2012CN101747262B Electron transporting-injection material and organic electroluminescent device using the same
11/07/2012CN101597259B Organic material and application thereof in organic electroluminescence device (OELD)
11/07/2012CN101166719B Bcrp/abcg2 inhibitor
11/07/2012CN101001846B Novel alkynyl derivatives as modulators of metabotropic glutamate receptors
11/06/2012US8304546 Quinolone compound and pharmaceutical composition
11/06/2012US8304427 Acylthiourea compound or salt thereof, and use thereof
11/01/2012WO2012149236A1 Novel bicyclic nitrogen containing heteroaryl tgr5 receptor modulators
11/01/2012WO2012147904A1 Polymerizable compound, polymerizable composition, polymer, and optically anisotropic material
11/01/2012WO2012106584A3 Pitavastatin salts
11/01/2012US20120277237 Novel alkynyl derivatives as modulators of metabotropic glutamate receptors
11/01/2012US20120277231 Quinolinyloxyphenylsulfonamides
11/01/2012US20120277230 Compounds useful for treating cancer
11/01/2012US20120277185 Pesticidal Carboxamides
1 ... 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 ... 277